Position in ERAS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$150,475,359
+$127,505,691 QoQ
Shares Held
9,300,084
+50.6% QoQ
Ownership
2.99%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 12.76252988682683.ToString("F0")%
Shared 0.ToString("F0")%
None 87.23747011317317.ToString("F0")%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,287,966,567 across 421 Biotechnology names. ERAS ranks #43 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in ERAS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $150,475,359 | 9,300,084 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,969,668 | 6,174,642 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,783,778 | 4,029,256 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,082,679 | 4,002,110 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,723,702 | 4,177,885 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $16,589,797 | 6,609,481 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $16,455,402 | 6,027,620 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,801,304 | 2,458,180 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,441,611 | 1,670,685 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,547,097 | 1,665,304 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,945,278 | 1,495,065 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,112,077 | 1,489,883 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,820,204 | 1,269,171 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $16,768,257 | 3,890,547 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $16,010,007 | 2,052,565 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $5,361,013 | 962,480 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,733,713 | 899,269 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,708,215 | 366,381 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,502,006 | 259,284 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||